Thanks DD, very interesting ...
EnableTS, Inc. announces acquisition of Medical Capital Management, LLC and New Management Team
Oct 25, 2011
OTC Disclosure & News Service
Parsippany, NJ -
October 25, 2011 - Parsippany, New Jersey – EnableTS, Inc. (Symbol ENTS.PK) today announced that on June 28, 2011, it acquired all of the issued and outstanding membership interests of Medical Capital Management, LLC (“MCM”) in exchange for the issuance of 75,000,000 shares of its common stock. MCM was acquired from Roger Findlay, Jody Samuels, our current President and director and Nancy Figueiredo, pursuant to which Mr. Findlay became our Chairman and Chief Executive Officer in June 2011 and Ms. Figueiredo became a director of our company and our Vice President of Marketing on October 14, 2011. In June 2011, we sold all of the assets related to our email management system to PRD Holdings Inc. which is controlled by our former sole officer and director Danny Jenkins, who resigned his officer and director positions with the company in June 2011. As consideration for the acquisition of the assets related to our email management system, an aggregate of 100,000,000 shares of our common stock held by PRD Holdings was returned to the company for cancellation. As a result of the acquisition of MCM and the cancellation of the 100,000,000 shares of our common stock by PRD Holdings we currently have 79,147,344 shares of common stock issued and outstanding.
Medical Capital Management, LLC (“MCM”) is a medical marketing company that assists and advises start-up, development stage and established operating private and public companies primarily in the medical industry, including, without limitation, companies that operate ambulatory surgical, magnetic resonance imaging, urgent care and orthopedic urgent care centers, medical billing,marketing and sales companies. In exchange for the services that MCM provides, it expects to receive cash and/or equity from its client companies.
MCM has a contract with Mulberry Ambulatory Surgical Center Limited Liability Company (“Mulberry ASC”) to assist it in seeking physicians and capital to build and operate the facility, as well as to assist Mulberry ASC in its selection and financing of the proper equipment for the facility. Additionally, MCM will assist with the negotiation of contracts with managed care companies, the selection of qualified personnel, implementing systems and procedures at the facility,assisting in the preparation of budgets, as well as assisting in setting up the facility for its day to day operations. In exchange for the services to be rendered, MCM has the option to acquire nine percent (9.0%) of the equity interests of Mulberry ASC.
Currently all of our operations are those of MCM, however, we intend to seek opportunistic situations in which we can acquire established businesses, or create new lines of business, that will add value to our company and our shareholders primarily in the medical industry.
The officers and directors of our company are Roger Findlay, Jody Samuels and Nancy Figueiredo, below are the biographies for each of Messrs. Findlay and Samuels and Ms. Figueiredo:
Roger Findlay is the Chairman of our board of directors and our Chief Executive Officer. Since December 2008, Mr. Findlay was the Managing Director of MCM. Mr. Findlay is a co-founder of MSA Management Companies, LLC (“MSA”) and was the President and a member of the management committee from February 2008 through 2009. MSA is a New Jersey limited liability company specializing in the development and management of surgical centers. Mr. Findlay continues to own an interest in MSA and advises MSA in connection with its capital raising and ongoing development activities. MSA currently operates three ambulatory surgery centers in New Jersey, with five in various stages of development, as well as one ambulatory surgery center in Columbus, Ohio and one in Las Vegas, Nevada. Mr. Findlay is the President and a member of each of MSC Management, LLC, a New Jersey limited liability company, which manages and holds an interest in an ambulatory surgery center in Millburn, New Jersey, and MSC Management of Morristown, L.L.C., a New Jersey limited liability company, which holds an interest in an ambulatory surgery center in Cedar Knolls, New Jersey; positions which he has held since 2005 and 2006, respectively. Mr. Findlay is also presently and has been since 1989, an advisor to Technology Services, Inc., a software support company for medical offices and commercial accounts which he co-founded, and was previously the President of Northern New Jersey Medical Management, Inc., the general partner of a diagnostic imaging center, a company which Mr. Findlay co-founded. From June 1990 through June 2002, Mr. Findlay served as President and Chairman of the board of directors of Modern Medical Modalities Corporation (OTC BB: MODM), a New Jersey corporation, which leased magnetic resonance imaging and computerized axial tomography equipment to hospitals and physicians, and which Mr. Findlay co-founded. From 1995 to 2003, Mr. Findlay was also the Chairman of the board of directors of RF Management Corp., an imaging center management company, whose securities were listed on the Nasdaq Small Cap Market.
Jody R. Samuels is our President, Secretary, Treasurer and a director and has served in such positions since June 2011. Currently Mr. Samuels is the President of JRS Consulting Co., a business, legal and financial consulting company, which advises public and private companies in connection with capital raising activities, legal issues,as well as other strategic business matters. From April 2006 through November 2010, Mr. Samuels was a partner of the law firm Richardson & Patel LLP, which is primarily a corporate and securities law firm with offices in New York City and Los Angeles. Mr. Samuels continues to represent public and private companies with respect to their corporate and securities legal matters in diverse industries, including medical, technology, manufacturing, consumer sales and others. Mr. Samuels has been a corporate attorney since 1996 and has represented both issuers and under writersin private and public financing and M&A transactions valued in excess of $1billion. Mr. Samuels received his Juris Doctorate from New York Law School in 1995 and his BA in Accounting from Brooklyn College in 1991.
Nancy Figueiredo is our Vice President of Marketing and a director of our company. Ms. Figueiredo currently works for Buzzbahn, LLC, a marketing company, where she is the creative director of marketing. With more than 20 years experience as a creative individual, Ms. Figueiredo has used her talents to oversee all phases of the design production process from concept to final release to printer. She has art directed projects for leading educational publishers and strategized with the marketing department to devise effective print ad campaigns, while managing a team of designers and electronic production personnel to complete multiple titles for submissions for adoptions. Ms. Figueiredo has held positions ranging from designer to art director throughout her career. From 2008 through 2011, Ms. Figueiredo was an art director at CCI, a New York art design firm. From 2007 to 2008, Ms. Figueiredo was a senior designer at Sadlier Publishing, where she was responsible for overseeing all phases of design production. From 2004 through 2007, Ms. Figueiredo was a design consultant with John Wiley & Sons and a senior designer with GGS Design. Ms. Figueiredo received an AAS from the Fashion Institute of Technology, New York, in 1990 where she graduated Magna Cum Laude. In 1993, Ms. Figuereido received her BFA from the Fashion Institute of Technology, New York. In 1992, Ms. Figueiredo was the first place winner of the nationwide AAF competition for design and execution of PSA’s and posters for the Urban League.
This press release is neither an offer to sell nor the solicitation of an offer to buy any securities of ENTS.
Forward-Looking Statements:
Statements contained in this press release, which are not historical facts, are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based largely on current expectations and are subject to a number of known and unknown risks, uncertainties and other factors beyond the Company's control that could cause actual events and results to differ materially from these statements. These risks include, without limitation, that there can be no assurance that any strategic opportunities will be available to the Company and that any strategic opportunities may only be available on terms not acceptable to the Company. These statements are not guarantees of future performance, and readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. ENTS undertakes no obligation to update publicly any forward-looking statements.
Contact:
<!--[if !supportLineBreakNewLine]-->
<!--[endif]-->
EnableTS, Inc.
Roger Findlay, CEO
973 285-9100
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
http://www.otcmarkets.com/stock/ENTS/news/EnableTS%2C-Inc.-announces-acquisition-of-Medical-Capital-Management%2C-LLC-and-New-Management-Team?id=36994&b=y
News 
Market Data 
Discover 
